Search Results for C4X

C4XD, Manchester drug firm, to delist from AIM

Manchester-based drug discovery company C4X Discovery Holdings plc (C4XD) has announced the proposed cancellation of its ordinary shares on AIM and re-registration as a private limited…


C4XD shares up 40% on AstraZeneca payment

Shares of Manchester-based drug discovery company C4X Discovery Holdings plc rose as much as 40% after it announced that AstraZeneca has triggered an $11 million…



C4XD, Manchester drug firm, sells rights to Indivior

Manchester-based drug discovery company C4X Discovery Holdings plc announced that Indivior will acquire the proprietary rights to C4XD’s oral Orexin-1 receptor antagonist C4X_3256 (INDV-2000) for substance…



C4XD, Manchester drug firm, appoints CSO

Manchester-based drug discovery company C4X Discovery Holdings plc announced the appointment of Nick Ray as its chief scientific officer (CSO) with immediate effect.  Ray joined C4XD in…